drugset / Trial / NCT00999219

A Study of FK199B to Compare Efficacy With Zolpidem by Polysomnography in Patients With Insomnia

NCT00999219

Phase 3 Completed 55 enrolled Astellas Pharma Inc
RandomizedCrossoverQuadruple-blindTreatment

Summary

This study is to investigate the efficacy and safety of FK199B (Zolpidem MR Tablet) by polysomnography in patients with insomnia, excluding patients with schizophrenia or manic-depressive psychosis.

Timeline

Start
2006-03
Primary completion
2007-07
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject FK199B Unknown Oral
Subject Zolpidem Small molecule Oral